Investing.com - Aadi Bioscience (NASDAQ: AADI) reported first quarter EPS of $-0.6800, $0.05 worse than the analyst estimate of $-0.6300. Revenue for the quarter came in at $5.4M versus the consensus estimate of $6.5M.
Aadi Bioscience's stock price closed at $2.11. It is up 12.8300% in the last 3 months and down -75.1500% in the last 12 months.
Aadi Bioscience saw #ERROR! positive EPS revisions and #ERROR! negative EPS revisions in the last 90 days. See Aadi Bioscience's stock price’s past reactions to earnings here.
According to InvestingPro, Aadi Bioscience's Financial Health score is "#error! performance".
Check out Aadi Bioscience's recent earnings performance, and Aadi Bioscience's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar